Brief: Shanghai Haohai Biological Technology Acquires Remaining 20% Stake In Unit
07/11/2025 14:44
Nov 7 (Reuters) - Shanghai Haohai Biological Technology Co Ltd 688366.SS: ACQUISITION OF REMAINING 20% STAKE IN UNIT DEAL FOR RMB74 MILLION Further company coverage: 688366.SS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shanghai Haohai Biological Technology
See all newsChina's Haohai Biological H1 revenue falls, partly hurt by end of Brighten Optix distribution
Brief: Shanghai Haohai Biological Technology Says Resignation Of Hou Yongtai As Exec Director, Chair
Brief: Shanghai Haohai Biological Technology Updates On Investigation Of Jiang Wei's Suspected Insider Trading Case
Brief: Shanghai Haohai Biological Technology Proposes To Elect Tian Min As An Additional Executive Director
Brief: Shanghai Haohai Biological Technology Posts Qtrly Net profit Attributable Of RMB73.6 Mln.